Table 5 The results of repeat donors with low level viral load who were repeat positive in the follow up stud
From: Characteristic of HBV nucleic acid amplification testing yields from blood donors in China
Donors | Donation date* | Donation type | Age | Gender | Times of Follow-up | NAT result groups | Method for NAT test | Alt NAT# | HBV-DNA (VLs, IU/mL) | Serological marker positive | |
|---|---|---|---|---|---|---|---|---|---|---|---|
BD1 | X | October 5, 2011 | PLT | 49 (1970) | Female | 30 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc |
X + 21 | July 2, 2013 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 73 | October 12, 2017 | FS | Non-repeated positive | ELITE | / | ||||||
X + 80 | May 4, 2018 | FS | Neg | ELITE | Pos | ||||||
BD2 | X | December 10, 2012 | PLT | 45 (1974) | Female | 9 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc |
X + 39 | March 2, 2016 | FS | Non-repeated positive | PLUS | / | ||||||
X + 67 | June 11, 2018 | FS | Neg | ELITE | Pos | ||||||
BD3 | X | April 19, 2011 | PLT | 62 (1957) | Male | 49 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc and anti-HBs |
X + 3 | July 16, 2011 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 21 | January 27, 2013 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 44 | December 20, 2014 | FS | Non-repeated positive | ULTRIO | / | ||||||
BD4 | X | June 3, 2011 | WB | 55 (1964) | Male | 6 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc and anti-HBs |
X + 16 | October 16, 2012 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 38 | August 9, 2014 | FS | Non-repeated positive | ULTRIO | / | ||||||
BD5 | X | September 28, 2011 | PLT | 41 (1978) | Male | 8 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc and anti-HBs |
X + 1 | December 2, 2011 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 7 | May 15, 2012 | FS | Non-repeated positive | ULTRIO | / | ||||||
BD6 | X | May 19, 2011 | PLT | 52 (1967) | Male | 97 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc and anti-HBe |
X + 23 | March 26, 2013 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 70 | February 22, 2017 | FS | Non-repeated positive | ELITE | / | ||||||
X + 73 | June 1, 2017 | FS | Neg | ELITE | Pos | ||||||
BD7 | X | November 20, 2011 | PLT | 51 (1968) | Female | 77 | Non-repeated positive | ULTRIO | / | Neg | Anti-HBc, anti-HBs and anti-HBe |
X + 21 | July 25, 2013 | FS | Non-repeated positive | ULTRIO | / | ||||||
X + 56 | July 3, 2016 | FS | Non-repeated positive | PLUS | / | ||||||
X + 72 | November 2, 2017 | FS | Non-repeated positive | ELITE | / | ||||||
BD8 | X | September 18, 2010 | PLT | 43 (1976) | Male | 5 | HBV-DNA positive | ULTRIO | / | < 12 | Anti-HBc |
X + 1 | October 30, 2010 | FS | HBV-DNA positive | ULTRIO | / | Neg | |||||
X + 6 | March 11, 2011 | FS | HBV-DNA positive | ULTRIO | / | 17.8 | |||||